TY - JOUR
T1 - Influence of corevalve revalving system implantation on mitral valve function
T2 - An Echocardiographic Study in Selected Patients
AU - De Chiara, Benedetta
AU - Moreo, Antonella
AU - De Marco, Federico
AU - Musca, Francesco
AU - Oreglia, Jacopo
AU - Lobiati, Elisabetta
AU - Bruschi, Giuseppe
AU - Belli, Oriana
AU - Mauri, Francesco
AU - Klugmann, Silvio
PY - 2011/10/3
Y1 - 2011/10/3
N2 - Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF,
AB - Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF,
KW - CoreValve ReValving system
KW - implantation depth
KW - mitral regurgitation
UR - http://www.scopus.com/inward/record.url?scp=80053196128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053196128&partnerID=8YFLogxK
U2 - 10.1002/ccd.23045
DO - 10.1002/ccd.23045
M3 - Article
C2 - 21805556
AN - SCOPUS:80053196128
VL - 78
SP - 638
EP - 644
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
SN - 1522-1946
IS - 4
ER -